semaglutide iih The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension: Body Weight 👁️ Managing IIH 🧠 ,

Given that a months supply of the prescription version costs upwards of $1,350, and that insurance coverage has plummeted as the drugs gain popularity as a weight loss aid, its no wonder some people are drawn in

However, compounded semaglutide, like all compounded drugs, is not FDA-approved and does not undergo FDA review for safety, effectiveness, or manufacturing

The fact that they accept insurance, provide ongoing support, and make the prescription affordable made all the difference

Combination therapy represents another approach

Lower doses may still activate GLP-1 receptors, but appetite suppression tends to scale with dose intensity